The RayStation treatment planning system implements a Monte Carlo (MC) algorithm for electron dose calculations. For a TrueBeam accelerator, beam modeling was performed for four electron energies (6, 9, 12, and 15 MeV), and the dose calculation accuracy was tested for a range of geometries. The suite of validation tests included those tests recommended by AAPM's Medical Physics Practice Guideline 5.a, but extended beyond these tests in order to validate the MC algorithm in more challenging geometries. For MPPG 5.a testing, calculation accuracy was evaluated for square cutouts of various sizes, two custom cutout shapes, oblique incidence, and heterogenous media (cork). In general, agreement between ion chamber measurements and RayStation dose calculations was excellent and well within suggested tolerance limits.
and bones, extended source to surface distance (SSDs), oblique incidence, and small irregular fields. 3, 4 In comparison to photon treatment planning, electron Monte Carlo (MC) dose calculation algorithms are more computationally efficient, requiring fewer histories to achieve a given statistical uncertainty. The relative speed and improved accuracy of electron MC algorithms has allowed their introduction into commercial treatment planning systems (TPS) in recent years.
The RayStation TPS implements a MC dose calculation algorithm for electron treatment planning that uses the VMC++ Monte Carlo code for in-patient energy transport and scoring. 5 VMC++ is a voxel-based Monte Carlo code that has been incorporated into several commercial planning systems, including Oncentra MasterPlan® and CMS XiO®. The RayStation implementation of this MC algorithm models several beamline components, including the jaws, MLCs, electron applicator scraper layers, and the electron cutout, in the generation of phase space data which is then fed into the VMC++ code in order to perform dose calculations in the patient geometry.
Several guidance documents exist to aid medical physicists in developing tests to validate and commission an electron MC dose calculation algorithm for treatment planning purposes. The AAPM Medical Physics Practice Guideline 5.a (MPPG 5.a) recommends validation tests for electron beams, including comparison of calculated vs. measured dose distributions for standard cutouts, custom cutouts at standard and extended SSDS, oblique incidence, and inhomogeneous phantom geometries. 6 Though the suite of tests recommended by MPPG 5.a represents the minimum testing that should be performed to commission an electron dose calculation algorithm, the tests are typically performed using simple geometries (e.g., water tank and a cork slab phantom) that do not fully explore the accuracy of more advanced Monte Carlo algorithms. AAPM Task Group
Report No. 105 addresses issues specifically associated with Monte
Carlo-based treatment planning algorithms; this task group report states that beam model validation should include measurements in heterogeneous phantom geometries, similar to those reported in the Electron Collaborative Working Group report. 1, 7, 8 The more complex validation phantom geometries used by the Electron Collaborative
Working Group include irregular surface contours (e.g., nose-shaped phantoms, stepped-surface phantoms) as well as internal 3D heterogeneities (e.g., bone and air cavities). Cygler et al. (2003) evaluated the VMC++ code using phantom geometries of varying degrees of complexity, including 1D (slab), 2D (rib), and 3D (small cylindrical) heterogeneities, as well as a complex phantom geometry designed to mimic the trachea and the spine. 9 Though studies have been done to quantify the accuracy of elec- and calculated R 50 was also evaluated.
2.C | Complex phantom validation
Four complex phantom geometries were used to test the electron Monte Carlo algorithm in RayStation beyond the testing current recommended by MPPG 5.a. These four complex phantom geometries were designed to mimic clinical cases and to be a more challenging test of the algorithm's ability to handle heterogeneities and irregular surface contours. All four phantoms were made in-house.
• Nose phantom: This phantom is composed entirely of solid water with a triangular piece to mimic the geometry of a nose • Breast phantom: This is a cylindrical solid water phantom with a diameter of 15.6 cm. The phantom has halves that are used to sandwich radiochromic film in an edge-on orientation [ Fig. 1(c) ].
There is no heterogeneous material in this phantom aside from the air pockets, but it was chosen to somewhat mimic the curvature of a breast for an enface electron beam treatment.
• Lung phantom: Similar to the geometry used for MPPG 5.a test 8.3, this rectangular slab phantom is composed of solid water and cork. From the proximal surface, there is 1 cm of solid water, followed by 4 cm of cork, and then 6 cm of solid water [ Fig. 1(d) ]. Radiochromic film is sandwiched in this phantom in the edge-on orientation in order to evaluate the algorithm's ability to predict penumbra broadening within the cork region.
For each of the phantoms, measurements were performed for each electron beam energy (6, 9, 12, and 15 MeV) using Gafchromic EBT3 radiochromic film (Ashland, Inc, Bridgewater, NJ, USA) oriented edge-on with respect to the beam at 100 cm SSD. 500 MU were delivered per irradiation. A 10 cm x 10 cm standard cutout was used for all measurements. Analysis of the film was performed in the Film QA Pro software (Ashland, Inc., Bridgewater, NJ, USA). A calibration curve was created using known doses ranging from 50 to 800 cGy for 12 MeV. For the other electron energies, the calibration curve was linearly scaled in the film analysis software using experimental films delivered to known doses for that particular energy (600 cGy).
Dose calculations were performed in RayStation to match the experimental conditions, with 500,000 histories per cm 2 and a uniform 2 mm dose grid. The calculated dose exported from the RayStation planning system was then manually registered to the film-measured dose using isodose lines (IDLs) as a guide to maximize the agreement. Gamma analysis was used to compare the film-measured dose against RayStation-calculated dose using the following criteria: 3% global dose difference, 3 mm distance-to-agreement, and a 10% dose threshold. Figure 2 shows the difference between measured output factors and RayStation-calculated output factors for 100, 105, and 110 cm SSD. Of the 312 output factors evaluated, 20 (6.4%) were outside of 3% and 5 (1.6%) were outside of 5%, with these larger errors generally being for the smallest cutout sizes within a given applicator. Table 2 shows the results of gamma analysis comparisons for all electron energies for the four complex validation phantoms. For the energy with the worst agreement for a given phantom Fig. 3 shows the overlay between the film-measured IDLs and the RayStation-calculated IDLs. Based on these results, the RayStation electron Monte Carlo algorithm is able to accurately calculate the hot spots due to the triangular nose geometry [ Fig. 3(a) ], changes in range due to bone [ Fig. 3(b) ], the effect of a curved patient surface [ Fig. 3(d) ], and penumbra broadening in lung [ Fig. 3(c) ]. The average agreement for gamma analysis across all phantoms and electron energies was 89.3% pixels passing for 3%/3 mm criteria.
2.D | Clinical implementation considerations

3.B | Complex phantom validation
3.C | Clinical implementation considerations 3.C.1 | Statistical uncertainty
Based on our initial experiences with electron planning in RayStation, we chose to perform clinical dose calculations using a 2 mm uniform dose grid and a final dose calculation using 500,000 histories per 
3.C.2 | Prescription methods
Our procedures for electron treatment planning in the Pinnacle planning system utilize a calculation point placed at the depth of dose maximum in order to prescribe dose based on an IDL (e.g., the 90% IDL Table 3 illustrates examples of volume-based prescriptions in RayStation that achieved similar coverage as the Pinnacle plans. There were several plans for which there is no contoured target and thus the prescription in the RayStation plan was point-based. Attempts were made to prescribe to the near minimum dose (D 98 ) of an isodose volume (i.e., a contour created based on voxels receiving ≥90% of the maximum dose). However, based on these limited cases, use of a point-based prescription resulted in MU more similar to the Pinnacle plans. Table 3 also lists the ratio of RayStation MU to Pinnacle MU for these clinical cases; based on this limited dataset there does not appear to be a systematic trend and whether RayStation or Pinnacle MU are higher is likely dependent on both the patient geometry and the prescription method. Based on this initial experience, we recommend that electron plans be created using volume-based prescriptions whenever there is a contoured target. Figure 4 shows the Pinnacle pencil beam algorithm dose distribution side-by-side with the RayStation-calculated dose for one of these clinical cases (the 5th case shown in Tables 3 and 4) , along with a DVH comparison for the PTV.
3.C.3 | Density overrides
The RayStation planning system does not take into account the density of structures outside of the external contour in the dose calculation unless the structure is designated as a special ROI type (Fixation, Support, or Bolus). The case shown in Fig. 4 contains a wire over the lumpectomy scar that was present at the time of the simulation scan but will not be present during treatment. Therefore the wire was contoured and overwritten to a density of air for both the Pinnacle and RayStation plans. For cases without bolus, our clinical practice allows the wire structure to either overlap with the external contour and be overwritten to air density (as was done for this particular treatment plan), or to be edited out of the external contour, both options that result in the density of the wire being set to zero. However, for cases with bolus, our clinical practice is to edit the wire out of the external contour, which removes the need to perform a density override of the wire and also makes the bolus created in the planning system conform to the patient contour better (i.e., less puckering). It should be noted that though the wire was accurately contoured and its ROI was overwritten to air density in • All profile and PDD comparisons resulted in gamma passing rates > 95%
Oblique incidence
• Absolute dose measurements agree within 2%
• All profile and PDD comparisons resulted in gamma passing rates > 95% 5%
Heterogeneous media (cork)
• Absolute dose measurements agree within 5%
• Distance to agreement near R50 was < 3 mm
The calculated crossline profiles for the small custom cutout were wider than measured for one of our TrueBeam machines. However, when this validation test was repeated on a matched TrueBeam linear accelerator, the profile agreement was excellent with passing rates > 95%. Measurement error or a small mismatch between the size of the cutout in the planning system vs. the physical cutout is suspected.
3.C.4 | Secondary MU calculations
Because of the transition to volume-based prescriptions, our procedures for performing secondary MU calculations, which were previously based on an IDL, also needed to be changed. Several comparisons between RayStation MU and Mobius3D MU were performed for clinical cases. To perform this comparison, a calculation point was placed at the depth of dose maximum in the RayStation plan in order to obtain a %IDL for the secondary MU calculation. Table 4 shows that several of these cases showed greater than 5% differences in MU calculated with Mobius3D vs.
RayStation. These differences arise from the different calculation
Percent error between RayStation-calculated output factors and measured output factors for various square cutout sizes, applicator sizes, electron energies, and source to surface distances. Errors > 3% but < 5% are highlighted in yellow, and those exceeding 5% are highlighted in red.
geometries in RayStation, which is able to handle irregular surface contours, heterogeneities, and oblique incidence, and Mobius3D, which performs a calculation in a homogeneous water phantom with normal beam incidence. In order to isolate differences due to electron output for a patient-specific cutout, a quality assurance plan was created for each patient plan in RayStation. For this quality assurance (QA) plan, the patient-specific cutout, beam energy, collimator angle, and SSD were used for a dose calculation using a water phantom and a normally incident electron beam. The dose calculated from this QA plan was then used to perform the secondary MU comparison. The use of this water phantom QA plan greatly improved the MU agreement, as expected and summarized in The worst agreement values for a given phantom geometry are highlighted in yellow. clinical cases, we found that there were generally larger differences for our secondary MU calculation performed using Mobius3D than we were accustomed to for Pinnacle pencil beam calculations. The larger differences are attributable to the more accurate handling of heterogeneities and irregular surface contours with the Monte Carlo algorithm. Therefore, our secondary MU calculation procedures were changed to include a dose calculation performed using the Monte Carlo algorithm for the patient-specific cutout and a normally incident electron beam on a water phantom. This QA water phantom calculation allows the secondary MU calculation to identify differences in output rather than highlighting differences in the sophistication of the dose calculation algorithm in the primary TPS vs. the secondary check software. water phantom dose calculation using the patient-specific cutout was incorporated into our secondary MU calculation procedures in order highlight differences in output rather than differences in the sophistication of the primary calculation vs. the secondary calculation.
| CONCLUSION
